Development and Validation of Oxyresveratrol Quantification Method in Artocarpus lacucha Roxb. Heartwood by Ultra–High Performance Liquid Chromatography

Main Article Content

Aussavashai Shuayprom
Thanawat Thongchin
Sayan Ruengkhet
Sakwichai Ontong

Abstract

Introduction and Objective: Oxyresveratrol is an active principle in the heartwood of Artocarpus lacucha Roxb. ex Buch.–Ham. (Ma Hat in Thai) with antioxidative, anti–inflammatory and pain–relieving activities. This heartwood has been used as an herbal ingredient in various traditional medicinal products and herbal health supplements in the markets. However, available analytical methods for the quality control of oxyresveratrol in A lacucha heartwoood are still practically complicated and inconvenient regarding the extraction process and analytical time. Therefore, this study aimed to develop new analytical method for the quantification assessment of oxyresveratrol in A. lacucha heartwood samples using ultra–high performance liquid chromatography (UHPLC) technique.


Methods: The study was divided into three steps, namely, 1) developing UHPLC method for the analysis of oxyresveratrol in A. lacucha heartwood, 2) testing the validity of the newly–developed analytical method, and 3) quantitative analysis of oxyresveratrol in 8 samples of
A. lacucha
Roxb. heartwood using new method.


Results: UHPLC method development for the analysis of oxyresveratrol in A. lacucha heartwood: It was found that oxyresveratrol was best extracted by reflux with methanol for
30 minutes. Chromatographic separation was achieved using ARC–18 column (4.6 x 150 mm,
2.7 µm) as the stationary phase, 0.1% ortho–phosphoric acid in water and 0.1% ortho–phosphoric acid in acetonitrile as the isocratic mobile phase, and detection with diode array detector (DAD) at 326 nm. Under these analytical conditions, the average retention time for oxyresveratrol was 4.76 minutes. Method validation: The calibration curve of oxyresveratrol was found to be linear at the concentration range of 14.33 – 229.32 µg/mL with correlation coefficient (r) of 0.9999. The percentage recoveries and % relative standard deviation (%RSD) were in the range of 98.03 – 98.70% and 0.52 – 0.87%, respectively. The limit of detection (LOD) and the limit of quantitation (LOQ) of oxyresveratrol was 0.274 and 0.912% w/w of the dried heartwood, respectively. Quantitative analysis of oxyresveratrol in 8 heartwood samples showed that the content of oxyresveratrol was in the range of 1.54 – 26.23% w/w (on a dry weight basis).


Discussion: The developed UHPLC method for determining oxyresveratrol content in A. lacucha heartwood met all acceptance criteria for analytical method validation. The newly developed method is rapid, with a simple, convenient, and efficient mobile phase preparation process, making it suitable for routine analysis of oxyresveratrol in A. lacucha heartwood. The analysis of eight heartwood samples revealed an average oxyresveratrol content of 8.80 ± 8.27% w/w (on a dry weight basis). This wide variation highlights significant quality differences among raw materials currently available in the domestic herbal market. Consequently, further research is needed to determine the optimal harvesting period for A. lacucha heartwood to ensure standardized quality for pharmaceutical and herbal product manufacturing.


Conclusion and Recommendation: The developed method is suitable for the quantitative analysis of oxyresveratrol in A. lacucha heartwood. Furthermore, additional research should be conducted to establish acceptance level of oxyresveratrol content in the monograph of “Kaen Ma Hat” or Artocarpus lacucha heartwood or in the Thai Herbal Pharmacopoeia (THP) in the future.

Article Details

Section
Original Articles
Author Biographies

Aussavashai Shuayprom, Medicinal Plant Research Institute, Department of Medical Sciences, 88/7 Tiwanon Road, Talat Khwan Subdistrict, Mueang District, Nonthaburi Province 11000, Thailand

N/A

Thanawat Thongchin, Medicinal Plant Research Institute, Department of Medical Sciences, 88/7 Tiwanon Road, Talat Khwan Subdistrict, Mueang District, Nonthaburi Province 11000, Thailand

N/A

Sakwichai Ontong, Medicinal Plant Research Institute, Department of Medical Sciences, 88/7 Tiwanon Road, Talat Khwan Subdistrict, Mueang District, Nonthaburi Province 11000, Thailand

N/A

References

Boonyaprapat N, Chokchaicharoenporn O. Mahad. Medicinal Plants indigenous to Thailand. Bangkok: Prachachon; 1999. p. 724–25. (in Thai)

Likhitwitayawuid K. Oxyresveratrol: sources, productions, biological activities, pharmacokinetics, and delivery systems. Molecules. 2021;26(14): 4212.

Borah HJ, Singhal R, Hazarika S. Artocarpus lakoocha Roxb.: an untapped bioresource of resveratrol from north east India, its extractive separation and antioxidant activity. Industrial Crops and Products. 2017;95:75–82.

Hu X, Liang Y, Zhao B, Wang Y. Oxyresveratrol protects human lens epithelial cells against hydrogen peroxide–induced oxidative stress and apoptosis by activation of Akt/HO–1 pathway. J Pharmacol Sci. 2019;139(3):166–73.

Singhatong S. Antioxidant and toxicity activities of Artocarpus lakoocha Roxb. heartwood extract. J Med Plant Res. 2010;4(10):947–53.

Phoolcharoen W, Sooampon S, Sritularak B, Likhitvitayawuid K, Kuvatanasuchati J, Pavasant P. Anti–periodontal bacterial activity of oxyresveratrol. Thai J Pharm Sci. 2012;36:92–4.

Teanpaisan R, Senapong S, Puripattanavong J. In vitro antimicrobial and antibiofilm activity of Artocarpus Lakoocha (Moraceae) extract against some oral pathogens. Trop J Pharm Res. 2014;13(7):1149–55.

Senapong S, Puripattanavong J, Teanpaisan R. Anticandidal and antibiofilm activity of Artocarpus lakoocha extract. Songklanakarin J Sci Technol. 2014;36(4):451–7.

Wongon M, Limpeanchob N. Inhibitory effect of Artocarpus lakoocha Roxb. and oxyresveratrol on α–glucosidase and sugar digestion in Caco–2 cells. Heliyon. 2020;6(3):e03458.

Chuanasa T, Phromjai J, Lipipun V, Likhitwitayawuid K, Suzuki M, Pramyothin P, et al. Anti–herpes simplex virus (HSV–1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic efficacy on cutaneous HSV–1 infection in mice. Antiviral Res. 2008;80(1):62–70.

Sasivimolphan P, Lipipun V, Likhitwitayawuid K, Takemoto M, Pramyothin P, Hattori M, Shiraki K. Inhibitory activity of oxyresveratrol on wild–type and drug–resistant varicella–zoster virus replication in vitro. Antiviral Res. 2009;84(1):95–7.

Lipipun V, Sasivimolphan P, Yoshida Y, Daikoku T, Sritularak B, Ritthidej G, Likhitwitayawuid K, Pramyothin P, Hattori M, Shiraki K. Topical cream–based oxyresveratrol in the treatment of cutaneous HSV–1 infection in mice. Antiviral Res. 2011;91(2):154–60.

Sasivimolphan P, Lipipun V, Ritthidej G, Chitphet K, Yoshida Y, Daikoku T, Sritularak B, Likhitwitayawuid K, Pramyothin P, Hattori M, Shiraki K. Microemulsion–based oxyresveratrol for topical treatment of herpes simplex virus (HSV) infection: physicochemical properties and efficacy in cutaneous HSV–1 infection in mice. AAPS PharmSciTech. 2012;13(4):1266–75.

Sritularak B, De–eknamkul W, Likhitwitayawuid K. Tyrosinase inhibitors from Artocarpus lakoocha. Thai J Pharm Sci. 1998;22(4):149–55.

Likhitwitayawuid K, Sornsute A, Sritularak B, Ploypradith P. Chemical transformations of oxyresveratrol (trans–2,4,3',5'–tetrahydroxystilbene) into a potent tyrosinase inhibitor and a strong cytotoxic agent. Bioorg Med Chem Lett. 2006;16(21):5650–3.

Sornsute A. Isolation and structure modification of oxyresveratrol from Artocarpus lakoocha

for tyrosinase inhibitory activity [Thesis]. Bangkok: Chulalongkorn University; 2006.

Ashraf MI, Shahzad M, Shabbir A. Oxyresveratrol ameliorates allergic airway inflammation via attenuation of IL–4, IL–5, and IL–13 expression levels. Cytokine. 2015;76(2):375–81.

Aziz RS, Siddiqua A, Shahzad M, Shabbir A, Naseem N. Oxyresveratrol ameliorates ethanol–induced gastric ulcer via downregulation of IL–6, TNF–alpha, NF–KB, and COX–2 levels, and upregulation of TFF–2 levels. Biomed Pharmacother. 2019;110:554–60.

Sunilkumar D, Drishya G, Chandrasekharan A, Shaji S. K, Bose C, Jossart J, Perry JP, Mishra N, Kumar GB, Nair BG. Oxyresveratrol drives caspase–independent apoptosis–like cell death in MDA–MB–231 breast cancer cells through the induction of ROS. Biochem Pharmacol. 2020;173:113724.

Povichit N, Phrutivorapongkul A, Suttajit M, Leelapornpisid P. Antiglycation and antioxidant activities of oxyresveratrol extracted from the heartwood of Artocarpus lakoocha Roxb. Maejo Int J Sci Technol. 2010;4:454–61.

Preyavichyapugdee M, Sangfuang M, Preyavichyapugdee N, Pootaeng–on Y, Sophon P. The in vitro effect of a crude extract from Artocarpus lakoocha Roxb. on Paramphistomum cervi. Silpakorn U Science &Tech J. 2017;11(1):36–46.

Prugsakij W. In vitro evaluation of anti–aging activity of Artocarpus lakoocha heartwood extract [Thesis]. Bangkok: Chulalongkorn University; 2006.

Palanuvej C, Issaravanich S, Tunsaringkarn T, Rungsiyothin A, Vipunngeun N, Ruangrungsi N, Likhitwitayawuid K. Pharmacognostic Study of Artocarpus lakoocha heartwood. J Health Res. 2018;21(4):257–62

Maneechai S, Likhitwitayawuid K, Sritularak B, Palanuvej C, Ruangrungsi N, Sirisa–Ard P. Quantitative analysis of oxyresveratrol content in Artocarpus lakoocha and 'Puag–Haad'. Med Princ Pract. 2009;18(3):223–7.

Rojsanga P, Sithisarn P. Validated TLC–densitometric method for determination of oxyresveratrol contents in ma–haad (Artocarpus lakoocha) heartwood extracts. Mahidol Univ J Pharm Sci. 2016;43(2):91–6.

Pattamadilok D, Sakpetch A, Thongsrirak P, Ontong S. Chemical quality of Artocarpus lakoocha heartwood. J Thai Trad Alt Med. 2558;13(2):115–22.

Radapong S, Sarker SD, Ritchie KJ. Oxyresveratrol possesses DNA damaging activity. Molecules. 2020;25(11):2577.

Duangdee N, Chamboonchu N, Kongkiatpaiboon S, Prateeptongkum S. Quantitative 1 HNMR spectroscopy for the determination of oxyresveratrol in Artocarpus lakoocha heartwood. Phytochem Anal. 2019;30(6):617–22.

Department of Medical Science. Practical guidelines for testing the accuracy of chemical analysis methods in the single laboratory setting. Nonthaburi: Department of Medical Science; 2006.

ICH Q2 (R1): Validation of Analytical Procedures: Text and Methodology. 2005.